Contact Info
Pharmacovigilance
На русский
Home
About us
Petrovax Today
Figures and Facts
History
R&D Center
Production
Quality control
Corporate social responsibility
HR policy
Contact Details
Products
Products
Pharmaceuticals
Pharmaceuticals
Polyoxidonium
®
Longidaze
®
Velson
®
Vaccines
Vaccines
Grippol
®
Plus
Grippol
®
Quadrivalent
Prevenar
®
13
Cosmetic products
Cosmetic products
Imoferaza
®
Pharmacovigilance
Partners
Exports
Strategic partnerships in Russia
International Projects and Alliances
Patients
Media
News
Video about company
Press Kit
Media Contacts
20 years
Site map
Home
Press Room
Back
News
News
Video about company
Press Kit
Media Contacts
All
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Petrovax sponsors All-Russia Forum ‘Public Immunity-2019’
Petrovax sponsors All-Russia Forum ‘Public Immunity-2019’
04.12.2019
Petrovax restyles its logo
Petrovax restyles its logo
22.11.2019
An Additional Component Can Triple Vaccine Efficiency, and...
An Additional Component Can Triple Vaccine Efficiency, and Scientists Explained How
08.11.2019
National assembly «Protected generation»
National assembly «Protected generation»
24.10.2019
Velson® TV campaign launched
Velson® TV campaign launched
17.10.2019
Petrovax completed Grippol® plus vaccine supplies to...
Petrovax completed Grippol® plus vaccine supplies to Russian and EEU markets on schedule
16.10.2019
Petrovax Day for pharma camp ‘FILIN’ students
Petrovax Day for pharma camp ‘FILIN’ students
03.10.2019
Influenza vaccine Grippol® Quadrivalent approved for...
Influenza vaccine Grippol® Quadrivalent approved for children 6 years and over
26.09.2019
NPO Petrovax Pharm launches Velson® for sleep normalization...
NPO Petrovax Pharm launches Velson® for sleep normalization and regulation of human biorhythms
06.08.2019
Follow-up to roundtable “Integration into the world...
Follow-up to roundtable “Integration into the world pharmaceutical market. The history of a Russian molecule”
18.07.2019
NPO Petrovax Pharm completes construction of a new...
NPO Petrovax Pharm completes construction of a new manufacturing facility
17.07.2019
Petrovax Pharm once again attested for EU GMP certificate
Petrovax Pharm once again attested for EU GMP certificate
11.07.2019
NPO Petrovax Pharm LLC’s office to change location
NPO Petrovax Pharm LLC’s office to change location
27.06.2019
German companies visit Petrovax Pharm facility
German companies visit Petrovax Pharm facility
05.06.2019
Congratulations on the 80th Birthday of Nekrasov Arkady...
Congratulations on the 80th Birthday of Nekrasov Arkady Vasilyevich!
11.05.2019
In Europe, the results of the latest study on the adjuvant...
In Europe, the results of the latest study on the adjuvant role as an influenza vaccine ingredient were presented
11.04.2019
NPO Petrovax Pharm is a prizewinner of the Award «Russian...
NPO Petrovax Pharm is a prizewinner of the Award «Russian Business Guide. People of the year».
01.04.2019
Petrovax Pharm continues building up export presence
Petrovax Pharm continues building up export presence
14.02.2019
Petrovax Pharm launches inaugural nationwide TV media...
Petrovax Pharm launches inaugural nationwide TV media campaign for Longidaze®
17.01.2019
Russian Health Week: Petrovax Pharm participates in...
Russian Health Week: Petrovax Pharm participates in PharmMedProm-2018 Exhibition and Russia’s Immunobiological Shield Congress
11.12.2018
«
1
2
3
4
5
»
This site contains information for medical and pharmaceutical professionals. To view the content, please, confirm that you have the appropriate qualifications.
Confirm
Cancel
